Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Gross Profit 2010-2023 | MKGAF

Merck annual/quarterly gross profit history and growth rate from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Merck gross profit for the quarter ending December 31, 2023 was $3.123B, a 9.99% decline year-over-year.
  • Merck gross profit for the twelve months ending December 31, 2023 was $13.413B, a 7.11% decline year-over-year.
  • Merck annual gross profit for 2023 was $13.413B, a 7.11% decline from 2022.
  • Merck annual gross profit for 2022 was $14.44B, a 1.06% decline from 2021.
  • Merck annual gross profit for 2021 was $14.595B, a 19.42% increase from 2020.
  
Merck Annual Gross Profit
(Millions of US $)
2023 $13,413
2022 $14,440
2021 $14,595
2020 $12,221
2019 $11,364
2018 $11,165
2017 $11,311
2016 $10,870
2015 $9,730
2014 $10,600
2013 $10,763
2012 $10,308
2011 $9,915
2010 $12,338
2009 $10,807
Merck Quarterly Gross Profit
(Millions of US $)
2023-12-31 $3,123
2023-09-30 $3,277
2023-06-30 $3,449
2023-03-31 $3,564
2022-12-31 $3,470
2022-09-30 $3,685
2022-06-30 $3,681
2022-03-31 $3,603
2021-12-31 $3,731
2021-09-30 $3,672
2021-06-30 $3,683
2021-03-31 $3,508
2020-12-31 $3,340
2020-09-30 $3,122
2020-06-30 $2,763
2020-03-31 $2,996
2019-12-31 $2,987
2019-09-30 $2,865
2019-06-30 $2,829
2019-03-31 $2,683
2018-12-31 $2,601
2018-09-30 $2,796
2018-06-30 $2,854
2018-03-31 $2,914
2017-12-31 $2,908
2017-09-30 $2,854
2017-06-30 $2,816
2017-03-31 $2,734
2016-12-31 $2,696
2016-09-30 $2,760
2016-06-30 $2,813
2016-03-31 $2,601
2015-12-31 $2,537
2015-09-30 $2,444
2015-06-30 $2,437
2015-03-31 $2,366
2014-12-31 $2,114
2014-09-30 $2,638
2014-06-30 $2,690
2014-03-31 $2,644
2013-12-31 $2,672
2013-09-30 $2,687
2013-06-30 $2,767
2013-03-31 $2,625
2012-12-31 $3,646
2012-09-30 $2,570
2012-06-30 $2,482
2012-03-31 $3,274
2011-12-31 $3,311
2011-09-30 $3,585
2011-06-30 $2,583
2011-03-31 $3,505
2010-12-31 $3,707
2010-09-30 $2,345
2010-06-30 $2,695
2010-03-31 $2,791
2009-12-31 $2,983
2009-09-30 $2,778
2009-06-30 $2,590
2009-03-31 $2,456
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $21.368B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $70.141B 28.83
Chugai Pharmaceutical (CHGCY) Japan $51.291B 22.93
Takeda Pharmaceutical (TAK) Japan $41.364B 6.70
Astellas Pharma (ALPMY) Japan $17.264B 27.26
Sandoz Group AG (SDZNY) Switzerland $14.500B 0.00
Shionogi (SGIOY) Japan $14.029B 12.14
Neurocrine Biosciences (NBIX) United States $13.708B 56.93
United Therapeutics (UTHR) United States $11.103B 11.89
Catalent (CTLT) United States $10.098B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.639B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.768B 6.86
Ionis Pharmaceuticals (IONS) United States $6.098B 0.00
Revolution Medicines (RVMD) United States $5.819B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.236B 0.00
Madrigal Pharmaceuticals (MDGL) United States $3.868B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.943B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.710B 0.00
Summit Therapeutics (SMMT) United States $2.491B 0.00
Indivior (INDV) United States $2.378B 11.27
Corcept Therapeutics (CORT) United States $2.312B 23.38
Dyne Therapeutics (DYN) United States $2.042B 0.00
PTC Therapeutics (PTCT) United States $1.953B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.914B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.840B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.811B 10.73
Evotec AG (EVO) Germany $1.807B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.732B 17.90
Avadel Pharmaceuticals (AVDL) Ireland $1.614B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Ardelyx (ARDX) United States $1.468B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.265B 11.88
Soleno Therapeutics (SLNO) United States $1.248B 0.00
4D Molecular Therapeutics (FDMT) United States $1.204B 0.00
Pacira BioSciences (PCRX) United States $1.186B 11.81
Xencor (XNCR) United States $1.185B 0.00
Collegium Pharmaceutical (COLL) United States $1.172B 7.21
Cronos Group (CRON) Canada $0.955B 0.00
Cassava Sciences (SAVA) United States $0.940B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.896B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.858B 0.00
USANA Health Sciences (USNA) United States $0.830B 13.07
Sage Therapeutics (SAGE) United States $0.817B 0.00
Relay Therapeutics (RLAY) United States $0.815B 0.00
Enliven Therapeutics (ELVN) United States $0.785B 0.00
ARS Pharmaceuticals (SPRY) United States $0.781B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.704B 0.00
Ocular Therapeutix (OCUL) United States $0.650B 0.00
Silence Therapeutics (SLN) United Kingdom $0.647B 0.00
ProKidney (PROK) United States $0.622B 0.00
Savara (SVRA) United States $0.615B 0.00
Siga Technologies (SIGA) United States $0.614B 9.09
Calliditas Therapeutics AB (CALT) Sweden $0.579B 0.00
Lyell Immunopharma (LYEL) United States $0.561B 0.00
Verve Therapeutics (VERV) United States $0.520B 0.00
OmniAb (OABI) United States $0.519B 0.00
Altimmune (ALT) United States $0.510B 0.00
Exscientia (EXAI) United Kingdom $0.482B 0.00
Korro Bio (KRRO) United States $0.470B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.444B 0.00
KalVista Pharmaceuticals (KALV) United States $0.443B 0.00
Tourmaline Bio (TRML) United States $0.410B 0.00
Larimar Therapeutics (LRMR) United States $0.404B 0.00
Lexeo Therapeutics (LXEO) United States $0.401B 0.00
Heron Therapeutics (HRTX) United States $0.383B 0.00
Esperion Therapeutics (ESPR) United States $0.377B 0.00
Nature's Sunshine Products (NATR) United States $0.365B 20.44
Harrow (HROW) United States $0.354B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.352B 0.00
Bioventus (BVS) United States $0.322B 0.00
Fractyl Health (GUTS) United States $0.322B 0.00
Lyra Therapeutics (LYRA) United States $0.309B 0.00
Organogenesis (ORGO) United States $0.302B 57.12
Aquestive Therapeutics (AQST) United States $0.288B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.282B 0.00
Nanobiotix S.A (NBTX) France $0.279B 0.00
Akebia Therapeutics (AKBA) United States $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.271B 0.00
Black Diamond Therapeutics (BDTX) United States $0.268B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.264B 0.00
Metagenomi (MGX) United States $0.253B 0.00
Xeris Biopharma Holdings (XERS) United States $0.252B 0.00
Pyxis Oncology (PYXS) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.248B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.226B 0.00
Foghorn Therapeutics (FHTX) United States $0.223B 0.00
Prelude Therapeutics (PRLD) United States $0.222B 0.00
Galectin Therapeutics (GALT) United States $0.217B 0.00
Avita Medical (RCEL) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Telomir Pharmaceuticals (TELO) United States $0.201B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Regulus Therapeutics (RGLS) United States $0.149B 0.00
Incannex Healthcare (IXHL) Australia $0.146B 0.00
CytoDyn (CYDY) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.138B 12.95
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.123B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.121B 2.54
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
VAXART, INC (VXRT) United States $0.116B 0.00
Relmada Therapeutics (RLMD) United States $0.112B 0.00
Inotiv (NOTV) United States $0.111B 0.00
GlycoMimetics (GLYC) United States $0.110B 0.00
OptiNose (OPTN) United States $0.102B 0.00
FibroGen (FGEN) United States $0.101B 0.00
Eliem Therapeutics (ELYM) United States $0.094B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
AlloVir (ALVR) United States $0.092B 0.00
ProPhase Labs (PRPH) United States $0.089B 0.00
PMV Pharmaceuticals (PMVP) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.078B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.075B 6.04
Journey Medical (DERM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.060B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.83
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.050B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
JanOne (JAN) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Protara Therapeutics (TARA) United States $0.035B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Unicycive Therapeutics (UNCY) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.031B 0.00
Nutriband (NTRB) United States $0.029B 0.00
DURECT (DRRX) United States $0.028B 0.00
Surrozen (SRZN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.024B 11.33
PolyPid (PYPD) Israel $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 1.04
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Addex Therapeutics (ADXN) Switzerland $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.24
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.39